ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,049, issued on April 22, was assigned to AstraZeneca AB (Sodertalje, Sweden).
"Methods of delaying pain progression and treating prostate cancer" was invented by Jinyu Kang (Wilmington, Del.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to methods for delaying pain progression in a subject receiving treatment for prostate cancer. This disclosure further relates to methods for treating prostate cancer, such as for example, treating prostate cancer in a subject having pain."
The patent was filed on Aug. 3, 2021, under Application No. 17/392,676.
*For further information, including images, charts and tables, please visit: http...